NON-PROFIT AND INDUSTRY Partnerships
Airstrip contracted with MCIRCC to determine indices and develop displays that would help clinicians best manage inpatient and outpatient Congestive Heart Failure (CHF). This management will help reduce chances of readmission and mortality, improving patient outcome while saving hospitals millions of dollars.
As part of this initiative, MCIRCC performed extensive research to identify the best indices for measuring CHF. By leveraging in-house cardiologist expertise and our available inpatient data warehouse, MCIRCC was able to determine the best indices and create a CHF “dashboard” screen to maximize a clinicians’ ability to detect trends and understand the CHF patient’s evolution during the inpatient stay.
Department of Defense
As the Department of Emergency Medicine began to look for ways to improve patient outcome for severe Traumatic Brain Injury patients, MCIRCC contacted the Department of Defense to serve as voice for clinicians treating TBI patients on the battlefield. Through this partnership, the Department of Defense has become closely involved win the Massey TBI Grand Challenge, offering advice, guidance, and expertise on the design and use of TBI innovations. We are proud to work with the DoD as part of the extending MCIRCC family!
MCIRCC works closely with In2Being to develop prototypes of our innovative devices. These initial prototypes help establish the initial proof of concept conceived by our Principal Investigators. In2Being developed the original prototypes for our DEVD and Ocular Impedance products.
Joyce and Don Massey Family Foundation
Since the beginning of this partnership in 2014, MCIRCC and the Massey Foundation have been on a remarkable journey to drive TBI injury research to a new level. Their investment in Michigan Medicine was an investment in the lives of millions of patients around the world who are impacted by TBI every year. Their gift has led to the creation of new technologies and therapeutics through the Massey TBI Grand Challenge, they've treated hundreds of patients in the Massey Emergency Critical Care Center (EC3), and inspired new research through education at the Joyce Massey TBI Summit.
MCIRCC works closely with Michigan Aerospace to develop prototypes of our innovative devices. These initial prototypes help establish the initial proof of concept conceived by our Principal Investigators. Michigan Aerospace developed the microchip currently being used on our DEVD product.
New Vital Signs
New Vital Signs has licensed several products from MCIRCC including Drive, Piezo Ring, and Ocular Impedance. As part of the license agreement, The company is creating prototypes for these products and preparing to take them into the marketplace.
MCIRCC works closely with SpringMatter to develop prototypes of our innovative devices. These initial prototypes help establish the initial proof of concept conceived by our Principal Investigators. SpringMatter has been instrumental in performing customer discovery for our DEVD product.
Jen Baird, the CEO of TroveaX reached out to the University of Michigan Tech Transfer Office in hopes of finding a new and innovative idea to take into the marketplace. She came across our Advanced Analytics Platform and was hooked. TroveaX now holds and exclusive license to our platform as well as two of our predictive analytics, AHI and Barreleye.
AHI is the Analytic for Hemodynamic Instability. It has the ability to predict a patient will decompensate several hours before normal vital signs signal an episode is occurring. Barreleye is an analytic used to detect Traumatic Brain Injury (TBI). Barreleye was funding through the Massey Grand Challenge. It has gone from inception to a licensed product in less than 3 years!